Cargando…
Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
The purpose of this study was to determine the potential benefits of combination therapy using dimercaptosuccinic acid modified iron oxide (DMSA-Fe(3)O(4)) magnetic nanoparticles (MNPs) combined with nontoxic concentration of bortezomib (BTZ) and gambogic acid (GA) on multiple myeloma (MM) RPMI-8226...
Autores principales: | Zhang, Wei, Qiao, Lixing, Wang, Xinchao, Senthilkumar, Ravichandran, Wang, Fei, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425315/ https://www.ncbi.nlm.nih.gov/pubmed/25995634 http://dx.doi.org/10.2147/IJN.S80795 |
Ejemplares similares
-
The Mitochondria-Independent Cytotoxic Effect of Leflunomide on RPMI-8226 Multiple Myeloma Cell Line
por: Adamczuk, Grzegorz, et al.
Publicado: (2021) -
Activation of murine 'T' lymphomas in the presence of a human myeloma cell line, RPMI-8226, in vivo.
por: Millar, B. C., et al.
Publicado: (1988) -
Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts
por: Agrawal, Ankita, et al.
Publicado: (2020) -
Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
por: Zdzisińska, Barbara, et al.
Publicado: (2008) -
Role and Mechanism of circ_0058063/miR-635 Axis in the Malignant Phenotype of Multiple Myeloma RPMI8226 Cells
por: Li, Xiaoya, et al.
Publicado: (2021)